Do Admitted COVID-19-Positive Patients on Anticoagulation Therapy Have a Reduced Hospital Stay and Disease Severity?

Background As of December 2021, the coronavirus disease 2019 (COVID-19) pandemic has resulted in the deaths of over 5 million people. It is known that infection with this virus causes a state of hypercoagulability. Because of this, there has been considerable debate on whether or not patients should...

Descripción completa

Detalles Bibliográficos
Autores principales: Nawaz, Haroon, Choudhry, Ayesha, Morse, William J, Zarnowski, Oskar, Patel, Harsh, Amin, Harshad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022187/
https://www.ncbi.nlm.nih.gov/pubmed/35475038
http://dx.doi.org/10.7759/cureus.23382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022187/
https://www.ncbi.nlm.nih.gov/pubmed/35475038
http://dx.doi.org/10.7759/cureus.23382

Ejemplares similares